Ligand Pharmaceuticals, Inc. (LGND)

191.39 +2.39 (+1.26%) USD  |  NASDAQ  |  Feb 25, 16:00
191.53 +0.14 (+0.07%) Pre-Market: 20:00
More

Ligand Pharmaceuticals Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Johnson & Johnson Upgrade
Elanco Animal Health, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade